Late-Breaking Data at EULAR 2022 Demonstrate Deucravacitinib Significantly Improved Disease Activity in Phase 2 PAISLEY Study in Systemic Lupus Erythematosus Pharmaceutical Investing
Jamieson Wellness Inc. to Acquire Nutrawise Health & Beauty Corporation, Owner of youtheory Brand Life Science Investing
Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Expanding Access & Affordability Life Science Investing
Abbott's FreeStyle Libre® 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor Pharmaceutical Investing
Albert Labs: Treating Cancer-Related Distress With Psilocybin-Based Medication Psychedelics Investing
LAWSUITS FILED AGAINST ABBV, SDIG and AUPH - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SDIG, AUPH and UPST Pharmaceutical Investing
SHAREHOLDER ALERT: VLTA ABBV LILM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
